865869-24-5

Basic information

• Product Name: 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate
• Synonyms: 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate;4-((tert-ButyldiMethylsilyl)oxy)cyclohex-1-en-1-yl trifluoroMethanesulfonate
• CAS NO: 865869-24-5
• Molecular Formula: C₁₃H₂₃F₃O₄SSi
• Molecular Weight: 360.4650296
• Mol File: 865869-24-5.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate(865869-24-5)
• EPA Substance Registry System: 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate(865869-24-5)

Safety Data

• Hazardous Substances Data: 865869-24-5(Hazardous Substances Data)

Usage

General Description

4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate is a chemical compound with the molecular formula C12H21F3O4SSi. It is a silyl triflate derivative of cycloaromatic compound and is commonly used as a protecting group in organic synthesis. 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate is often used to protect alcohols and phenols, and it can be easily removed under mild conditions to reveal the original functional groups. It is a highly reactive compound that is sensitive to air and moisture, and it should be handled with caution in a controlled laboratory environment. This chemical has applications in pharmaceutical and agrochemical industries, as well as in academic research for the synthesis of complex organic molecules.

Upstream product

• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 55145-45-4 4-(tert-butyldimethylsilyloxy)cyclohexanone 
• 145100-51-2 N-(5-chloropyridin-2-yl)-1,1,1-trifluoro-N-[(trifluoromethyl)sulphonyl]methanesulphonamide 
• 1025373-45-8 trifluoromethanesulfonic acid anhydride 
• 112906-39-5 8-[(tert-butyldimethylsilyl)oxy]-1,4-dioxaspiro[4,5]decane 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 22428-87-1 4,4-ethylenedioxycyclohexan-1-ol 

Downstream Products

• 216392-10-8 4-[(tert-butyldimethylsilyl)oxy]-1-vinylcyclohexene 
• 216392-11-9 4-vinylcyclohex-3-enol 
• 216392-12-0 4-[(methoxymethyl)oxy]-1-vinylcyclohexene 
• 1227177-64-1 4-(2-fluoropyridin-3-yl)cyclohex-3-enol 
• 1350445-23-6 [2-fluoro-4-(4-hydroxy-cyclohex-1-enyl)-phenyl]-carbamic acid benzyl ester 
• 1350445-24-7 methanesulfonic acid 4-(4-benzyloxycarbonylamino-3-fluoro-phenyl)-cyclohex-3-enyl ester 
• 1350445-25-8 {4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohexyl]-2-fluoro-phenyl}-carbamic acid benzyl ester 
• 1350445-26-9 4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohexyl]-2-fluoro-phenylamine 
• 1350445-29-2 2-{4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohexyl]-2-fluoro-phenyl}-1-oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid tert-butyl ester 
• 1350445-33-8 2-[2-fluoro-4-(4-hydroxy-cyclohexyl)-phenyl]-1-oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid tert-butyl ester 
• 1350444-85-7 {2-fluoro-4-[4-((S)-2-methyl-pyrrolidin-1-yl)-cyclohex-1-enyl]-phenyl}-carbamic acid benzyl ester 
• 1350445-16-7 {4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohex-1-enyl]-phenyl}-carbamic acid benzylester 
• 1350445-22-5 {4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohex-1-enyl]-2-fluoro-phenyl}-carbamic acidbenzyl ester 

Relevant articles and documents

Electrochemical Synthesis of (Aza)indolines via Dehydrogenative [3+2] Annulation: Application to Total Synthesis of (±)-Hinckdentine A

An electrochemical synthesis of functionalized (aza)indolines through dehydrogenative [3+2] annulation of arylamines with tethered alkenes has been developed. Previous reported syntheses through similar inter- and intramolecular annulation reactions requi

AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

Pyridine and pyrimidine compounds: or a pharmaceutically acceptable salt thereof, wherein m, n, R1, R2, R3, R4, R5, R6, R7, X1, X2, X3, X4, X5, X6, X7, X8, and Y are as defined in the specification; or a pharmaceutically acceptable salt thereof, wherein ring A, m, n, y, R2, R3, R4, R5, R6, R7, R8, R9, X1, X2, and ring A are as defined in the specification; and or a pharmaceutically acceptable salt thereof, wherein m, n, y, R2, R3, R4, R5, R6, R7, R9, X1, X2, and ring A are as defined in the specification; compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

COMPOUNDS AND METHODS FOR MODULATING FXR

Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.